Tag: cancer immunotherapy mechanisms

Yousefian, S., Schubert, ML., Minafra, A.R. et al. A distinct CAR-T cell phenotype mediates therapeutic response at limited doses. Nat ...

Researchers at the Icahn School of Medicine at Mount Sinai report that a rare subset of dendritic cells—specifically dendritic cell ...

Programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors have emerged as transformative agents in oncology, revolutionizing the ...

In a groundbreaking advance that could fundamentally transform cancer treatment protocols, researchers from The University of Texas at Austin and ...

In the relentless pursuit of more effective cancer immunotherapies, recent research has unveiled a groundbreaking mechanism by which the modulation ...